×
About 5,035 results

ALLMedicine™ Helicobacter Pylori Infection Center

Research & Reviews  1,762 results

Prevalence estimates of Helicobacter species infection in pancreatic and biliary tract ...
https://doi.org/10.1111/hel.12866
Helicobacter Osaki T, Lin Y et. al.

Jan 11th, 2022 - Helicobacter pylori infection is a well-established risk factor for gastric cancer and has been linked to other gastrointestinal diseases, including pancreatic and biliary tract cancers; however, the relevance of enterohepatic non-H. pylori helico...

Pepsinogen II in gastritis and Helicobacter pylori infection.
https://doi.org/10.1111/hel.12872
Helicobacter Di Mario F, Crafa P et. al.

Jan 9th, 2022 - In the gastric mucosa, pepsinogen II (PgII) is produced/secreted by glands in the mucus-secreting antral and cardia compartments, but also by the chief cells and the oxyntic glands. Increasing PgII serum levels are associated with the whole spectr...

Association between Helicobacter pylori infection and growth outcomes in children: A me...
https://doi.org/10.1111/hel.12861
Helicobacter Xu C, Wu Y et. al.

Jan 9th, 2022 - Multiple studies have reported the association between Helicobacter pylori (H. pylori) infection and children's growth. The results of these studies are controversial. Our meta-analysis aimed to evaluate the association between H. pylori infection...

Effect of Helicobacter pylori infection on malignancy of undifferentiated-type gastric ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734290
BMC Gastroenterology; Tanaka M, Hoteya S et. al.

Jan 8th, 2022 - Although almost all cases of gastric cancer are caused by Helicobacter pylori (HP) infection, there are some rare exceptions. Furthermore, the clinicopathological characteristics of gastric cancer may differ depending on HP infection status. This ...

Modern approach to the diagnosis of Helicobacter pylori infection.
https://doi.org/10.1111/apt.16566
Alimentary Pharmacology & Therapeutics; Dore MP, Graham DY

Jan 7th, 2022 - Modern approach to the diagnosis of Helicobacter pylori infection.|2022|Dore MP,Graham DY,|

see more →

Guidelines  7 results

AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Exp...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740554
Gastroenterology Shah SC, Piazuelo MB et. al.

Aug 30th, 2021 - The purpose of this Clinical Practice Update Expert Review is to provide clinicians with guidance on the diagnosis and management of atrophic gastritis, a common preneoplastic condition of the stomach, with a primary focus on atrophic gastritis du...

AGA Clinical Practice Update on the Management of Refractory Helicobacter pylori Infect...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281326
Gastroenterology Shah SC, Iyer PG et. al.

Feb 2nd, 2021 - The purpose of this CPU Expert Review is to provide clinicians with guidance on the management of Helicobacter pylori after an initial attempt at eradication therapy fails, including best practice advice on specific regimen selection, and consider...

British Society of Gastroenterology guidelines on the diagnosis and management of patie...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709778
Gut Banks M, Graham D et. al.

Jul 7th, 2019 - Gastric adenocarcinoma carries a poor prognosis, in part due to the late stage of diagnosis. Risk factors include Helicobacter pylori infection, family history of gastric cancer-in particular, hereditary diffuse gastric cancer and pernicious anaem...

Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children...
https://doi.org/10.1097/MPG.0000000000001594
Journal of Pediatric Gastroenterology and Nutrition; Jones NL, Koletzko S et. al.

May 26th, 2017 - Because of the changing epidemiology of Helicobacter pylori infection and low efficacy of currently recommended therapies, an update of the European Society for Paediatric Gastroenterology Hepatology and Nutrition/North American Society for Pediat...

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.
https://doi.org/10.1038/ajg.2016.563
The American Journal of Gastroenterology; Chey WD, Leontiadis GI et. al.

Jan 11th, 2017 - Helicobacter pylori (H. pylori) infection is a common worldwide infection that is an important cause of peptic ulcer disease and gastric cancer. H. pylori may also have a role in uninvestigated and functional dyspepsia, ulcer risk in patients taki...

see more →

Drugs  62 results see all →

Clinicaltrials.gov  63 results

Helicobacter Pylori Rescue Treatment in Patients Allergic to Penicillin
https://clinicaltrials.gov/ct2/show/NCT05135182

Nov 30th, 2021 - Helicobacter pylori(H.pylori), which infects about 50% of the global population,has been recognized as a main risk factor of multiple gastric pathologies,especially non-cardiac gastric cancer. Strongly evidence supports that H.pylori eradication i...

Helicobacter Pylori First-line Treatment Containing Tetracycline in Patients Allergic to Penicillin
https://clinicaltrials.gov/ct2/show/NCT05129176

Nov 24th, 2021 - Helicobacter pylori(H.pylori), which infects about 50% of the global population, has been recognized as a main risk factor of multiple gastric pathologies, especially non-cardiac gastric cancer. Strongly evidence supports that H.pylori eradication...

Helicobacter Pylori Rescue Treatment Containing Tetracycline in Patients Allergic to Penicillin
https://clinicaltrials.gov/ct2/show/NCT04264663

Nov 18th, 2021 - Helicobacter pylori(H.pylori), which infects about 50% of the global population, has been recognized as a main risk factor of multiple gastric pathologies, especially non-cardiac gastric cancer. Strongly evidence supports that H.pylori eradication...

Pathogen-microbiome Interaction During Helicobacter Pylori Infection
https://clinicaltrials.gov/ct2/show/NCT05121025

Nov 16th, 2021 - Helicobacter pylori colonizes the stomach of about half of the world's population, including about 20-30% of adults in Germany. In some cases, this colonization can lead to chronic inflammation of the gastric mucosa, which can lead to various seri...

Effectiveness of GastimunHp Plus in Supporting the Treatment of Peptic Ulcer Disease With Helicobacter Pylori Infection
https://clinicaltrials.gov/ct2/show/NCT04025983

Oct 19th, 2021 - Challenges in the treatment of Helicobacter pylori (H. pylori) include increasing antimicrobial resistance and patient's low tolerance to some regimens. Lactobacillus johnsonii (L. johnsonii) and Immunoglobulin Y (IgY) have been shown to decrease ...

see more →

News  119 results

OPT-PEACE Calls Out GI Injuries With Post-PCI Antiplatelets
https://www.medscape.com/viewarticle/962697

Nov 10th, 2021 - A novel noninvasive endoscopy trial lends further support for the safety of single antiplatelet therapy after a 6-month course of dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention (PCI). Results from the OP...

Diagnosing and Managing Atrophic Gastritis: Expert Review
https://www.medscape.com/viewarticle/961530

Oct 25th, 2021 - A new clinical practice update expert review for the diagnosis and management of atrophic gastritis (AG) from the American Gastroenterological Association focuses on cases linked to Helicobacter pylori infection or autoimmunity. Dr Shailja C. Shah...

Gastric cancer: Family history–based H. pylori strategy would be cost effective
https://www.mdedge.com/internalmedicine/article/246539/gastroenterology/gastric-cancer-family-history-based-h-pylori
Jim Kling

Sep 23rd, 2021 - Testing for and treating Helicobacter pylori infection among individuals with a family history of gastric cancer could be a cost-effective strategy in the United States, according to a new model published in the journal Gastroenterology. sgame/thi.

Screening and Treating H. Pylori in Those at High Risk for Gastric Cancer Appears Cost-Effective
https://www.medscape.com/viewarticle/958503

Sep 14th, 2021 - NEW YORK (Reuters Health) - Screening for and treating Helicobacter pylori infection in those at high risk for gastric cancer is cost effective, a new modeling study shows. "This modeling study suggests that even after accounting for costs of trea...

Network meta-analysis ranks first-line H. pylori regimens
https://www.mdedge.com/gihepnews/article/242916/ibd-intestinal-disorders/network-meta-analysis-ranks-first-line-h-pylori
Jim Kling, MDedge News

Jul 14th, 2021 - A network meta-analysis of current first-line dual, triple, and quadruple therapies for Helicobacter pylori infection found that vonoprazan triple therapy was most effective, while standard triple therapy of a proton pump inhibitor (PPI), amoxicil.

see more →

Patient Education  1 results see all →